News

FDA’s Drug Chief Pick at Odds With RFK Jr.'s Revolving Door Vow
The appointment of a seasoned pharmaceutical executive, George Tidmarsh, to run the FDA’s drug center underscores the ...
Infectious Disease Advisor3h
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research
The US FDA has appointed George Francis Tidmarsh, MD, PhD, as director of the Center for Drug Evaluation and Research.
The New York Sun16h
EU Finds No Major Health Concerns With RFK Jr.’s Public Enemy No. 1 — Fluoride
The review notes that the current legal limit for drinking water in the bloc is 1.5 milligrams of fluoride per liter, which ...
STAT22h
Safety of fluoride supplements, and freedom of choice, debated at FDA meeting
But it’s unclear if the evidence provided to support continued use of fluoridated supplements will matter. The FDA said in ...
The Philadelphia Tribune25m
Prescription fluoride faces FDA scrutiny despite widespread support from providers and the public
The US Food and Drug Administration appears poised to continue with a plan to ban prescription fluoride supplements at a time ...
Bristol Myers Squibb taps Cristian Massacesi as CMO
Bristol Myers Squibb appoints Cristian Massacesi as EVP, Chief Medical Officer, & Head of Development starting Aug 2025.
MedPage Today20h
FDA 'Expert Panels' Raise Concerns of Evading Regulations, Ethics
Bypassing its standard pathways for scientific discussions, FDA has recently held a slew of so-called "expert panels" that ...
Gilead wins EU backing for twice-yearly HIV PrEP therapy
Gilead (NASDAQ:GILD) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA) as ...